KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Finished Goods (2016 - 2025)

Historic Finished Goods for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $4.1 billion.

  • Abbott Laboratories' Finished Goods fell 103.04% to $4.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year decrease of 103.04%. This contributed to the annual value of $3.7 billion for FY2024, which is 623.42% down from last year.
  • Per Abbott Laboratories' latest filing, its Finished Goods stood at $4.1 billion for Q3 2025, which was down 103.04% from $4.3 billion recorded in Q2 2025.
  • Abbott Laboratories' Finished Goods' 5-year high stood at $4.3 billion during Q2 2025, with a 5-year trough of $3.0 billion in Q3 2021.
  • Over the past 5 years, Abbott Laboratories' median Finished Goods value was $3.8 billion (recorded in 2023), while the average stood at $3.7 billion.
  • Per our database at Business Quant, Abbott Laboratories' Finished Goods skyrocketed by 2349.89% in 2022 and then tumbled by 623.42% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' Finished Goods stood at $3.1 billion in 2021, then grew by 23.5% to $3.8 billion in 2022, then rose by 3.71% to $3.9 billion in 2023, then dropped by 6.23% to $3.7 billion in 2024, then rose by 11.62% to $4.1 billion in 2025.
  • Its Finished Goods stands at $4.1 billion for Q3 2025, versus $4.3 billion for Q2 2025 and $4.1 billion for Q1 2025.